ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.070,76
0,44%
S&P 500
5.157,13
0,57%
US Dollar vs BRL
5,071
-0,03%
Bitcoin
63.881,59
-0,18%
Brent Oil
83,445
0,38%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) Notícias

LLY

Eli Lilly (LLY)

Eli Lilly and Co
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:LLY
DataHoraFonteTítuloCódigoCompanhia
30/04/202410:07IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
30/04/202408:59IH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
30/04/202408:55IH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
30/04/202407:45PR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
17/04/202407:15PR Newswire (US)Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesityNYSE:LLYEli Lilly and Co
16/04/202411:00PR Newswire (US)Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results AnnouncementNYSE:LLYEli Lilly and Co
03/04/202408:12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:LLYEli Lilly and Co
11/03/202417:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
11/03/202417:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
10/03/202417:00PR Newswire (US)More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab studyNYSE:LLYEli Lilly and Co
08/03/202408:45PR Newswire (US)U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of DonanemabNYSE:LLYEli Lilly and Co
07/03/202410:00PR Newswire (US)Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity CareNYSE:LLYEli Lilly and Co
05/03/202419:00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual MeetingNYSE:LLYEli Lilly and Co
20/02/202412:00PR Newswire (US)Lilly to Participate in Cowen's 44th Annual Health Care ConferenceNYSE:LLYEli Lilly and Co
13/02/202419:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:LLYEli Lilly and Co
09/02/202413:56Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
09/02/202411:30PR Newswire (US)Philip Johnson to Retire as Lilly TreasurerNYSE:LLYEli Lilly and Co
08/02/202418:51Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:LLYEli Lilly and Co
07/02/202419:08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LLYEli Lilly and Co
06/02/202408:45PR Newswire (US)Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 GuidanceNYSE:LLYEli Lilly and Co
06/02/202408:27IH Market NewsUS Index Futures Mixed, Oil Prices Edge HigherNYSE:LLYEli Lilly and Co
29/01/202408:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest newsNYSE:LLYEli Lilly and Co
29/01/202408:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street HighlightsNYSE:LLYEli Lilly and Co
25/01/202410:45Dow Jones NewsEli Lilly Executive VP of Global Quality Johna Norton to RetireNYSE:LLYEli Lilly and Co
25/01/202410:00PR Newswire (US)Johna Norton to Retire as Lilly Executive Vice President of Global QualityNYSE:LLYEli Lilly and Co
23/01/202414:00PR Newswire (US)Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter MeetingNYSE:LLYEli Lilly and Co
23/01/202412:00PR Newswire (US)Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial GuidanceNYSE:LLYEli Lilly and Co
22/01/202407:48IH Market NewsWall Street Highlights: Sony Abandons Billion-Dollar Merger, SolarEdge Announces 16% Workforce Reduction, and MoreNYSE:LLYEli Lilly and Co
10/01/202410:45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsNYSE:LLYEli Lilly and Co
05/01/202412:39Dow Jones NewsTrending: Lilly Launches Direct-to-Consumer WebsiteNYSE:LLYEli Lilly and Co
 Apresentando as notícias mais relevantes sobre:NYSE:LLY

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
LUPA3
LUPATECH ON
BOV
AZEV4
AZEVEDO PN
BOV
BRKM5
BRASKEM PNA
BOV
IFCM3
Infracommerce Caxaas ON
BOV
TELB4
TELEBRAS PN
BOV
PRIO3
PETRORIO ON
BOV
KRSA3
Kora Saude Participacoes... ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV3
AZEVEDO ON
BOV
ETER3
ETERNIT ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados